Clinical diabetes : (Record no. 8994)

MARC details
000 -LEADER
fixed length control field 03644cam a22002534a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230830144651.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 050513s2006 paua b 001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1416002731
040 ## - CATALOGING SOURCE
Original cataloging agency BUL
Transcribing agency BUL
Modifying agency BUL
Language of cataloging eng
Description conventions rda
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WK 810
Item number F676c 2006
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Fonseca, Vivian A.
245 10 - TITLE STATEMENT
Title Clinical diabetes :
Remainder of title translating research into practice /
Statement of responsibility, etc. Vivian A. Fonseca.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Philadelphia, PA :
Name of publisher, distributor, etc. Saunders Elsevier,
Date of publication, distribution, etc. c2006.
300 ## - PHYSICAL DESCRIPTION
Extent xxi, 661 p. :
Other physical details ill. (some col.) ;
Dimensions 29 cm. +
Accompanying material 1 CD-ROM (4 3/4 in.)
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents<br/><br/>Section 1: Pathophysiology<br/>chapter 1: Scope of the problem: The diabetes and metabolic syndrome epidemic<br/>chapter 2: Type 1 Diabetes: immunology and genetics<br/>chapter 3: Type 2 Diabetes: Insulin resistance, Beta cell dysfunction and other metabolic and hormonal abnormalities<br/>chapter 4: The Biochemical consequences of hyperglycemia<br/>chapter 5: The pathogenesis and treatment of high-risk obesity<br/>chapter 6: The metabolic syndrome and its effects on cardiovascular risks<br/>chapter 7: Endothelial dysfunction in diabetes<br/>chapter 8: Diabetes and inflammation <br/><br/>Section II : Complications<br/>chapter 9: Diabetic ketoacidosis and hyperglycemic hyperrosmolar syndrome<br/>chapter 10: Hypoglycemia in diabetes <br/>chapter 11: Diabetic Neuropathies<br/>chapter 12: Diabetic nephropathy<br/>chapter 13: Erectile dysfunction in diabetes<br/>chapter 14: The Diabetic foot<br/>chapter 15: Managing cardiovascular disease and evens in the patient with diabetes<br/>chapter 16: Diabetic retinopathy<br/>chapter 17: Diagnotic testing for coronary artery disease in diabetic patients<br/><br/>Section III: Lifestyle management<br/>chapter 18: Primar prevention of Type 2 diabetes mellitus<br/>chapter 19: Medical nutrition therapy for type 1 and type 2 diabetes<br/>chapter 20: Diabetes education<br/>chapter 21: Stress and depression in disease<br/>chapter 22: Exercise in diabetes<br/><br/>Section IV: Pharmacologic therapy<br/>chapter 23: Insulin secretagogues <br/>chapter 24: Insulin -sensitizing and insulin-sparing drugs<br/>chapter 25: Glucosidase inhibitors<br/>chapter 26: Type 2 Diabetes therapy: choosing oral agents<br/>chapter 27: Lip management in diabetes<br/>chapter 28: Hypertension in diabetes<br/>chapter 29: Insulin strategies in Type 1 and Type 2 Diabetes mellitus<br/>chapter 30: Beyond insulin therapy<br/>chapter 31: Pharmacologic agents and nutritional supplements in the treatment of obesity<br/>chapter 32: Physiologic insulin replacement with continuous subcutaneous insulin infusion: insulin pump therapy<br/>chapter 33: Glucose monitoring of the present and future<br/>chapter 34: Pancreas, kidney and islet transplantation: what every physician needs to know<br/><br/>Section V: Special populations and situations<br/>chapter 35: Diabetes and pregnancy<br/>Chapter 36: Diabetes management in the hospital settling<br/>chapter 37: Diabetes mellitus in children and adolescents<br/>chapter 38: Diabetes in older adults<br/>chapter 39: Diabetes in African Americans<br/>Chapter 40: Diabetes in Latin Americans<br/>Chapter 41: Diabetes in Asians<br/>Chapter 42: New drugs and diabetes risk<br/><br/>Section VI: Management approaches<br/>chapter 43: Running a diabetes clinic<br/>Chapter 44: Using computers and technology for diabetes care<br/>chapter 45: Pearls from major clinical trials: approaches to improving outcome of persons with diabetes
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus
General subdivision physiopathology.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus
General subdivision therapy.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Evidence-Based Medicine.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book Open Access
Classification part WK 810 F676c 2006
Item part 1
Call number prefix WK 810
Call number suffix F676c 2006
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Inventory number Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Dewey Decimal Classification     Health Sciences Library Health Sciences Library 01/11/2022 Donation 00066   WK 810 F676C 2006 MBAL22010758 01/11/2022 1 01/11/2022 Book Open Access